Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2015 Nov;25(11):1181-4.
doi: 10.1089/thy.2015.0222. Epub 2015 Oct 14.

Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public Involvement

Petros Perros  1 , Colin M Dayan  2 , A Jane Dickinson  3 , Daniel G Ezra  4 , Janis L Hickey  5 , Christoph Hintschisch  6 , George Kahaly  7 , John H Lazarus  2 , Marian Ludgate  2 , Beate Bartès  8 , Caroline J MacEwen  9 , Anna L Mitchell  1 , Dan Morris  10 , Nicole O'Connor  11 , Simon H Pearce  12 , Geoffrey E Rose  13 , Mario Salvi  14 , Wilmar M Wiersinga  15 , Alyson Williamson  11 ; Thyroid Eye Disease Amsterdam Declaration Implementation Group UK; European Group on Graves’ Orbitopathy
Affiliations
Editorial

Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public Involvement

Petros Perros et al. Thyroid. 2015 Nov.
No abstract available

PubMed Disclaimer

Figures

<b>FIG. 1.</b>
FIG. 1.
Flow diagram outlining the processes for prioritization and formulation of research questions.
See this image and copyright information in PMC

References

    1. Perros P, Neoh C, Dickinson J. 2009. Thyroid eye disease BMJ 338:b560. - PubMed
    1. Terwee CB, Dekker FW, Mourits MP, Gerding MN, Baldeschi L, Kalmann R, Prummel MF, Wiersinga WM. 2001. Interpretation and validity of changes in scores on the Graves' ophthalmopathy quality of life questionnaire (GO-QOL) after different treatments. Clin Endocrinol (Oxf) 54:391–398 - PubMed
    1. Kahaly GJ, Petrak F, Hardt J, Pitz S, Egle UT. 2005. Psychosocial morbidity of Graves' orbitopathy. Clin Endocrinol (Oxf) 63:395–402 - PubMed
    1. Ponto KA, Merkesdal S, Hommel G, Pitz S, Pfeiffer N, Kahaly GJ. 2013. Public health relevance of Graves' orbitopathy. J Clin Endocrinol Metab 98:145–152 - PubMed
    1. Wang Y, Smith TJ. 2014. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci 55:1735–1748 - PMC - PubMed

Publication types

LinkOut - more resources